Skip to main navigation Skip to search Skip to main content

Ruthenafuran Complexes Supported by the Bipyridine-is(diphenylphosphino)methane Ligand Set: Synthesis and Cytotoxicity Studies

Chi-Fung Yeung, Sik-Him Tang, Zhe Yang, Tsun-Yin Li, Ka-Kit Li, Yuen-Man Chan, Hau-Lam Shek, Kai-Wa Io, King-Ting Tam, Shek-Man Yiu, Man-Kit Tse, Chun-Yuen Wong*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

95 Downloads (CityUHK Scholars)

Abstract

Mononuclear and dinuclear Ru(II) complexes cis-[Ru(k2-dppm)(bpy)Cl2] (1), cis-[Ru(k2-dppe)(bpy)Cl2] (2) and [Ru2(bpy)2(μ-dpam)2(μ-Cl)2](Cl)2 ([3](Cl)2) were prepared from the reactions between cis(Cl), cis(S)-[Ru(bpy)(dmso-S)2Cl2] and diphosphine/diarsine ligands (bpy = 2,2 '-bipyridine; dppm = 1,1-bis(diphenylphosphino)methane; dppe = 1,2-bis(diphenylphosphino)ethane; dpam = 1,1-bis(diphenylarsino)methane). While methoxy-substituted ruthenafuran [Ru(bpy)(k2-dppe)(C^O)]+ ([7]+; C^O = anionic bidentate [C(OMe)CHC(Ph)O]- chelate) was obtained as the only product in the reaction between 2 and phenyl ynone HC≡C(C=O)Ph in MeOH, replacing 2 with 1 led to the formation of both methoxy-substituted ruthenafuran [Ru(bpy)(k2-dppm)(C^O)]+ ([4]+) and phosphonium-ring-fused bicyclic ruthenafuran [Ru(bpy)(P^C^O)Cl]+ ([5]+; P^C^O = neutral tridentate [(Ph)2PCH2P(Ph)2CCHC(Ph)O] chelate). All of these aforementioned metallafuran complexes were derived from Ru(II)-vinylidene intermediates. The potential applications of these metallafuran complexes as anticancer agents were evaluated by in vitro cytotoxicity studies against cervical carcinoma (HeLa) cancer cell line. All the ruthenafuran complexes were found to be one order of magnitude more cytotoxic than cisplatin, which is one of the metal-based anticancer agents being widely used currently.
Original languageEnglish
Article number1709
JournalMolecules
Volume27
Issue number5
Online published5 Mar 2022
DOIs
Publication statusPublished - Mar 2022

Funding

The work described in this paper was supported by the Research Grants Council of Hong Kong SAR (CityU 11305920 and T42-103/16-N) and City University of Hong Kong (7005604).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • ruthenium
  • alkyne activation
  • metallafuran
  • cytotoxicity
  • UNCONVENTIONAL ALKYNE ACTIVATIONS
  • RUTHENIUM COMPLEXES
  • TERMINAL ALKYNES
  • GOLD CATALYSIS
  • METAL
  • VINYLIDENE
  • CYCLOISOMERIZATION
  • HETEROCYCLES
  • STRATEGY
  • NITROGEN

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

RGC Funding Information

  • RGC-funded

Fingerprint

Dive into the research topics of 'Ruthenafuran Complexes Supported by the Bipyridine-is(diphenylphosphino)methane Ligand Set: Synthesis and Cytotoxicity Studies'. Together they form a unique fingerprint.

Cite this